8
Participants
Start Date
January 31, 2009
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Pemetrexed
Pemetrexed (Alimta) 500mg/\^2 administered intravenously over approximately 10-minutes on Day 1 of a 21-day cycle x 3 cycles
Radiation Therapy
"Radiation will start between days -1 to 2 from day 1 of cycle 1. Day 1 radiotherapy must be a Monday, Tuesday, or Wednesday.~The planned radiation dose is 60 Gy in 2.0 Gy fractions. The entire PTV, including primary tumor and areas of known nodal disease, shall receive 60 Gy at 2.0 Gy fractions, 5 fractions/week for 30 fractions over 6 weeks."
Fox Chase Cancer Center Extramural Research Program, Rockledge
Pennsylvania Oncology-Hematology Associates, Philadelphia
IN Onc/Hem Associates, Indianapolis
Indiana University Simon Cancer Center, Indianapolis
Community Regional Cancer Center, Indianapolis
Monroe Medical Associates, Munster
Northern Indiana Cancer Research Consortium, South Bend
Fort Wayne Oncology & Hematology, Inc, Fort Wayne
Medical Consultants, P.C., Muncie
Cancer Care Center of Southern Indiana, Bloomington
Providence Medical Group, Terre Haute
Horizon Oncology Center, Lafayette
NorthShore University Health System - Kellogg Cancer Center, Evanston
Northwestern University Feinberg School of Medicine, Chicago
Medical & Surgical Specialists, LLC, Galesburg
Siteman Cancer Center, St Louis
Providence Portland Medical Center, Portland
Hematology Oncology Associates S.J., P.A., Mount Holly
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Hoosier Cancer Research Network
OTHER